These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25874486)

  • 21. Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.
    Jiang Z; Jiang J; Yang H; Ge Z; Wang Q; Zhang L; Wu C; Wang J
    Oncol Rep; 2014 Mar; 31(3):1249-54. PubMed ID: 24452445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aurora kinases are essential for PKC-induced invasion and matrix metalloproteinase-9 expression in MCF-7 breast cancer cells.
    Noh EM; Lee YR; Hong OY; Jung SH; Youn HJ; Kim JS
    Oncol Rep; 2015 Aug; 34(2):803-10. PubMed ID: 26044736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells.
    Wu CC; Yu CT; Chang GC; Lai JM; Hsu SL
    Biochem Biophys Res Commun; 2011 Feb; 405(2):168-72. PubMed ID: 21216229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma.
    Wang H; Luo QF; Peng AF; Long XH; Wang TF; Liu ZL; Zhang GM; Zhou RP; Gao S; Zhou Y; Chen WZ
    Int J Mol Med; 2014 Mar; 33(3):633-9. PubMed ID: 24366211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NF-κB pathway is critically implicated in the oncogenic phenotype of human osteosarcoma cells.
    Tan B; Yuan Z; Zhang Q; Xiqiang X; Dong J
    J Appl Biomed; 2021 Dec; 19(4):190-201. PubMed ID: 34907738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tim-3 facilitates osteosarcoma proliferation and metastasis through the NF-κB pathway and epithelial-mesenchymal transition.
    Feng ZM; Guo SM
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Punicalagin suppresses osteosarcoma growth and metastasis by regulating NF-κB signaling.
    Wang XZ; Zhang SF; Yang ZH; Ye ZW; Liu J
    J Biol Regul Homeost Agents; 2020; 34(5):1699-1708. PubMed ID: 33148374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells.
    Zhang F; Chen A; Chen J; Yu T; Guo F
    Asian Pac J Cancer Prev; 2011; 12(1):239-45. PubMed ID: 21517265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
    Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
    Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma.
    Zhao Z; Jin G; Yao K; Liu K; Liu F; Chen H; Wang K; Gorja DR; Reddy K; Bode AM; Guo Z; Dong Z
    Mol Carcinog; 2019 Jun; 58(6):1056-1067. PubMed ID: 30790360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
    Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signaling.
    Fu Q; Jiang Y; Zhang D; Liu X; Guo J; Zhao J
    Mol Cell Biochem; 2016 Jul; 418(1-2):189-98. PubMed ID: 27344168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells.
    Nadeau MÈ; Rico C; Tsoi M; Vivancos M; Filimon S; Paquet M; Boerboom D
    BMC Cancer; 2015 Jun; 15():479. PubMed ID: 26104798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway.
    Wang Z; Cao CJ; Huang LL; Ke ZF; Luo CJ; Lin ZW; Wang F; Zhang YQ; Wang LT
    Oncotarget; 2015 Jun; 6(16):14191-208. PubMed ID: 25987128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
    Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
    Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis.
    Yamamoto S; Tomita Y; Hoshida Y; Sakon M; Kameyama M; Imaoka S; Sekimoto M; Nakamori S; Monden M; Aozasa K
    Clin Cancer Res; 2004 Jan; 10(2):651-7. PubMed ID: 14760088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
    Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
    Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.
    Ho PW; Goradia A; Russell MR; Chalk AM; Milley KM; Baker EK; Danks JA; Slavin JL; Walia M; Crimeen-Irwin B; Dickins RA; Martin TJ; Walkley CR
    Oncogene; 2015 May; 34(22):2922-33. PubMed ID: 25043296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma.
    Yan J; Wang Q; Zou K; Wang L; Schwartz EB; Fuchs JR; Zheng Z; Wu J
    Mol Med Rep; 2015 Jul; 12(1):498-502. PubMed ID: 25760445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.